Junctional protein regulation by sphingosine kinase 2 contributes to blood-brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 6, 2012, Pages 1014-1023

  Wacker, Bradley K ^a   Freie, Angela B ^a   Perfater, Jennifer L ^a   Gidday, Jeffrey M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bioactive lipids; focal stroke; neuroprotection; neurovascular unit

Indexed keywords

CLAUDIN 5; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; OCCLUDIN; PROTEIN ZO1; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 2; TYLOXAPOL; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; C57BL 6 MOUSE; CONTROLLED STUDY; HYPOXIA; HYPOXIC PRECONDITIONING; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; ANTIGENS, CD; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CADHERINS; CLAUDINS; HUMANS; ISCHEMIC PRECONDITIONING; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; STROKE;

EID: 84861885063     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.3     Document Type: Article

References (43)

1. Adamson RH, Sarai RK, Altangerel A, Thirkill TL, Clark JF, Curry FR (2010) Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. Cardiovasc Res 88:344-51
2. An P, Xue YX (2009) Effects of preconditioning on tight junction and cell adhesion of cerebral endothelial cells. Brain Res 1272:81-8
3. Aviv RI, d'Esterre CD, Murphy BD, Hopyan JJ, Buck B, Mallia G, Li V, Zhang L, Symons SP, Lee TY (2009) Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology 250:867-77
4. Blondeau N, Lai Y, Tyndall S, Popolo M, Topalkara K, Pru JK, Zhang L, Kim H, Liao JK, Ding K, Waeber C (2007) Distribution of sphingosine kinase activity and mRNA in rodent brain. J Neurochem 103:509-17 (Pubitemid 47498013)
5. Czech B, Pfeilschifter W, Mazaheri-Omrani N, Strobel MA, Kahles T, Neumann-Haefelin T, Rami A, Huwiler A, Pfeilschifter J (2009) The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem Biophys Res Comm 389:251-6
6. Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J, Kinnunen A, Baumruker T (2009) FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 19:254-66
7. Gesuete R, Orsini F, Zanier ER, Albani D, Deli MA, Bazzoni G, De Simoni MG (2011) Glial cells drive preconditioning-induced blood-brain barrier protection. Stroke 42:1445-53
8. Hasegawa Y, Suzuki H, Sozen T, Rolland W, Zhang JH (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41:368-74
9. Hoang MV, Nagy JA, Senger DR (2011) Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood 117:1751-60
10. Hua F,Ma J, Ha T, Kelley J,Williams DL, Kao RL, Kalbfleisch JH, Browder IW, Li C (2008) Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J Neuroimmunol 199:75-82
11. Igarashi J, Michel T (2008) S1P and eNOS regulation. Biochim Biophys Acta 1781:489-95
12. Jiao H,Wang Z, Liu Y,Wang P, Xue Y (2011) Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci 44:130-9
13. Karliner JS (2004) Mechanisms of cardioprotection by lysophospholipids. J Cell Biochem 92:1095-103
14. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S (2004) Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 56:468-77 (Pubitemid 39319336)
15. Le Bras A, Lionneton F, Mattot V, Lelievre E, Caetano B, Spruyt N, Soncin F (2007) HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 26:7480-9 (Pubitemid 350158718)
16. Lee JF, Zeng Q, Ozaki H, Wang L, Hand AR, Hla T, Wang E, Lee MJ (2006) Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J Biol Chem 281:29190-200 (Pubitemid 44507063)
17. Li Y, Lu ZY, Ogle M, Wei L (2007) Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice. Neurochem Res 32:2132-41 (Pubitemid 350059857)
18. Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill Jr AH, Milstien S, Spiegel S (2005) SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingo-lipid metabolism. J Biol Chem 280:37118-29 (Pubitemid 41587796)
19. Masada T, Hua Y, Xi G, Ennis SR, Keep RF (2001) Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat. J Cereb Blood Flow Metab 21:22-33 (Pubitemid 32016836)
20. McColl BW, Rothwell NJ, Allan SM (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 28:9451-62
21. McNeill H, Ryan TA, Smith SJ, Nelson WJ (1993) Spatial and temporal dissection of immediate and early events following cadherin-mediated epithelial cell adhesion. J Cell Biol 120:1217-26 (Pubitemid 23064176)
22. Mehta D, Konstantoulaki M, Ahmmed GU, Malik AB (2005) Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates rac activation and adherens junction assembly in endothelial cells. J Biol Chem 280:17320-8 (Pubitemid 41389201)
23. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL (2005) Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25:11113-21 (Pubitemid 41747151)
24. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-60 (Pubitemid 36578587)
25. Obrenovitch TP (2008) Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 88:211-47
26. Paik JH, Skoura A, Chae SS, Cowan AE, Han DK, Proia RL, Hla T (2004) Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev 18:2392-403 (Pubitemid 39304686)
27. Park SW, Kim M, Chen SW, Brown KM, D'Agati VD, Lee HT (2010) Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Lab Invest 90:1209-24
28. Pfeilschifter W, Czech-Zechmeister B, Sujak M, Mirceska A, Koch A, Rami A, Steinmetz H, Foerch C, Huwiler A, Pfeilschifter J (2011) Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochem Biophys Res Comm 413:212-7
29. Sandoval KE, Witt KA (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32:200-19
30. Schnitzer SE, Weigert A, Zhou J, Brune B (2009) Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. Mol Cancer Res 7:393-401
31. Stuart RO, Sun A, Bush KT, Nigam SK (1996) Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores. J Biol Chem 271:13636-41 (Pubitemid 26185412)
32. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923-34
33. Vessey DA, Li L, Jin Z-Q, Kelley M, Honbo N, Zhang J, Karliner JS (2011) A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid Med Cell Longevity, 2011:8; doi:10.1155/2011/961059
34. Wacker BK, Park TS, Gidday JM (2009) Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2. Stroke 40:3342-8
35. Wang L, Chiang ET, Simmons JT, Garcia JG, Dudek SM (2011) FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. Eur Respir J 38:78-88
36. Wang L, Dudek SM (2009) Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 77:39-45
37. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, Liao JK, Lo EH, Waeber C (2011) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 69:119-29
38. Weiss N, Miller F, Cazaubon S, Couraud PO (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788:842-57
39. Willis CL, Meske DS, Davis TP (2010) Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab 30:1847-59
40. Wong V (1997) Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol 273:C1859-67
41. Yung LM, Wei Y, Qin T, Wang Y, Smith CD, Waeber C (2011) Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. Stroke 43:199-204
42. Zhao J, Singleton PA, Brown ME, Dudek SM, Garcia JG (2009) Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1- phosphate-stimulated human endothelium: role in barrier enhancement. Cell Signal 21:1945-60
43. Zhu D, Wang Y, Singh I, Bell RD, Deane R, Zhong Z, Sagare A, Winkler EA, Zlokovic BV (2010) Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood 115:4963-72